Viewing Study NCT04422392


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-01-31 @ 12:01 AM
Study NCT ID: NCT04422392
Status: TERMINATED
Last Update Posted: 2023-08-30
First Post: 2020-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer
Sponsor:
Organization: